Loss of LLGL1 Expression Correlates with Diffuse Gastric Cancer and Distant Peritoneal Metastases.
Alexander DesukiFrank StaibInes GockelMarkus MoehlerHauke LangStefan BiesterfeldAnnett MadererPeter Robert GalleMartin R BergerCarl Christoph SchimanskiPublished in: Canadian journal of gastroenterology & hepatology (2019)
LLGL1 is coexpressed with E-cadherin. Loss of expression of either protein is associated with diffuse gastric cancer and peritoneal metastases. LLGL1 does not impact on proliferation or epithelial-mesenchymal transition (EMT) rather increasing cellular adhesion.